Fax: (507) 284-1803
Original Article
You have full text access to this OnlineOpen article
Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma
Article first published online: 23 MAY 2005
DOI: 10.1002/cncr.21166
Copyright © 2005 American Cancer Society
Additional Information
How to Cite
McWilliams, R. R., Rabe, K. G., Olswold, C., De Andrade, M. and Petersen, G. M. (2005), Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma. Cancer, 104: 388–394. doi: 10.1002/cncr.21166
Publication History
- Issue published online: 29 JUN 2005
- Article first published online: 23 MAY 2005
- Manuscript Accepted: 9 MAR 2005
- Manuscript Revised: 2 FEB 2005
- Manuscript Received: 27 DEC 2004
Funded by
- Lustgarten Foundation for Pancreas Cancer Research
- National Cancer Institute. Grant Number: R01 CA97075
- Mayo Clinic SPORE in Pancreatic Cancer. Grant Numbers: P20 CA 10270, R25T CA 92049
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , , , ABO blood group, hepatitis B viral infection and risk of pancreatic cancer, International Journal of Cancer, 2012, 131, 2Direct Link:
- 2, , , , , , , , , , Extrapancreatic Malignancies in Patients With Pancreatic Cancer, Pancreas, 2012, 41, 2, 212
- 3, , , , , , , Incidence of subsequent pancreatic adenocarcinoma in patients with a history of nonpancreatic primary cancers, Cancer, 2012, 118, 5Direct Link:
- 4, Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals, Journal of Gastroenterology, 2011, 46, 11, 1249
- 5, , , , Family History of Cancer and Tobacco Exposure in Index Cases of Pancreatic Ductal Adenocarcinoma, Journal of Oncology, 2011, 2011, 1
- 6, , , , , , , , , , , , , , , , Germline PKHD1 mutations are protective against colorectal cancer, Human Genetics, 2011, 129, 3, 345
- 7, , , , , , , , , , , Risk Factors of Familial Pancreatic Cancer in Japan, Pancreas, 2011, 40, 6, 974
- 8, , , , , , , , Screening for pancreatic cancer in a high-risk population with serum CA 19-9 and targeted EUS: a feasibility study, Gastrointestinal Endoscopy, 2011, 74, 1, 87
- 9, , , , A Population-Based Description of Familial Clustering of Pancreatic Cancer, Clinical Gastroenterology and Hepatology, 2010, 8, 9, 812
- 10, Factores de riesgo y diagnóstico temprano del cáncer de páncreas, GastroenterologÃa y HepatologÃa, 2010, 33, 5, 382
- 11, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan), International Journal of Cancer, 2010, 127, 6Direct Link:
- 12, , , , , , , , , , Genotype and haplotype analysis of TP53 gene and the risk of pancreatic cancer: an association study in the Czech Republic, Carcinogenesis, 2010, 31, 4, 666
- 13
- 14, , , , , , , , ABO Blood Group and the Risk of Pancreatic Cancer, JNCI Journal of the National Cancer Institute, 2009, 101, 6, 424
- 15, , , , , Familial association of pancreatic cancer with other malignancies in Swedish families, British Journal of Cancer, 2009, 101, 10, 1792
- 16, , , , , , , , Family history of various cancers and pancreatic cancer mortality in a large cohort, Cancer Causes & Control, 2009, 20, 8, 1261
- 17, Genetic predisposition and environmental risk factors to pancreatic cancer: A review of the literature, Mutation Research/Reviews in Mutation Research, 2009, 681, 2-3, 299
- 18, , Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis, Familial Cancer, 2008, 8, 2, 109
- 19, , , , , , , , , Risk of Other Cancers in Individuals with a Family History of Pancreas Cancer, Journal of Gastrointestinal Cancer, 2008, 38, 2-4, 119
- 20, , , A Clinical and Economic Evaluation of Endoscopic Ultrasound for Patients at Risk for Familial Pancreatic Adenocarcinoma, Pancreatology, 2007, 7, 5-6, 514
- 21, , , , , , , , , , , , , , , Cancer Risk among the Relatives of Patients with Pancreatic Ductal Adenocarcinoma, Pancreatology, 2007, 7, 5-6, 459

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)